GI

GI

The latest ESMO guidelines concerning GI cancers

1 April 2024

Dr Jeroen Dekervel, a GI oncologist at UZ Leuven, and Dr Francesco Sclafani, a...

GI

The latest ESMO guidelines concerning squamous cell carcinoma

1 April 2024

Dr Francesco Sclafani, a GI oncologist at Institut Jules Bordet, Hôpital...

GI

Episode 12: The RATIONALE-306 study solidifies checkpoint inhibition therapy in ESCC

27 March 2024

GI

Episode 11: Sotorasib plus panitumumab increases PFS in metastatic KRAS G12C mutated colorectal cancer patients: CodeBreak 300

20 March 2024

GI

Episode 10: MOUNTAINEER-02 introducing TUC with Tras as a new standard for HER2+ RAS WT mCRC patients

13 March 2024

GI

Episode 9: First data from CheckMate 8WH investigating double immunotherapy as a first line treatment in MSI-H/dMMR metastatic colon cancer

6 March 2024

GI

Episode 8: Neo-adjuvant immunotherapy and pCR as a biomarker in G/GEJ cancer: insights from the KEYNOTE-585 + MATTERHORN study

28 February 2024

GI

Episode 7: The KEYNOTE 811 trial

21 February 2024

GI

Episode 6: Fruquintinib, a new drug in refractory, metastatic colorectal cancer: results from the FRESCO-2 trial

14 February 2024

GI

Episode 5: The SUNLIGHT trial: new standard third line therapy for metastatic colorectal cancer

20 December 2023